The deal gives Mirum access to Bluejay’s monoclonal antibody brelovitug, which is currently in Phase III trials.

Gorakhpur , Uttar Pradesh Chief Minister Yogi Adityanath on Wednesday warned that the two biggest threats facing today's youth are drug abuse and smartphone addiction, urging them to stay away from ...

Biocytogen (Beijing) Pharmaceutical Technology Co., Ltd. ("Biocytogen," SSE: 688796; HKEX: 02315), a global biotechnology company advancing innovative drug discovery, today announced its successful ...

Acquisition of Staccato® One Breath Technology®, a proprietary platform technology with broad therapeutic ...

The biannual AustinPx Amorphous Solid Dispersions (ASD) Workshop is a place for collaboration and innovation. Hear firsthand ...

Two Russian men have been arrested for allegedly selling drugs using QR code stickers posted throughout Bangkok that used AI ...

After a year of progress, scientists say they are on the cusp of turning AI-designed antibodies into potential therapies. In ...

South Korea will require advertisers to label their ads made with artificial intelligence technologies from next year as it ...

Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based developer of advanced gel-based oral delivery ...

This year, the researchers announced they had designed two antibiotics to go after superbugs. The AI combined millions of ...

Polydopamine-coated magnetic liposomes offer insight into the lectin–glycan interactions in motion. By observing minute ...

And why many scientists are freaked out about the first serious for-profit company moving into the solar geoengineering field.